A cure for presbyopia

Share it:

Apr 3, 2016

A Game-Changing Approach to Presbyopia: SimVis Gekko Redefines Visual Solutions

The new era in presbyopia management: Sim+Vis revolutionizes visual options

Presbyopia, a common age-related vision condition, has long been a challenge in ophthalmology. While a cure for presbyopia remains elusive, researchers and innovators are tirelessly working to find ways to enhance patient management and satisfaction. In this article, we explore a groundbreaking solution that allows patients to experience various visual corrections before making treatment decisions: SimVis, a wearable device developed by 2EyesVision.


Simulating Visual Options

One of the key hurdles in addressing presbyopia is enabling patients to comprehend the treatment options available to them. Verbal explanations often fall short of providing an accurate understanding, especially for complex concepts like multifocal vision. Enter SimVis, a wearable device designed to simulate different correction types in real-life scenarios.

Developed by a team from the Visual Optics and Biophotonics Lab at the Institute of Optics in Madrid, Spain, SimVis allows patients to experience improved near vision and reduced distance visual quality associated with multifocal lenses.


The Power of Simultaneous Vision

Sim+Vis leverages the concept of simultaneous vision, superimposing near and far images to simulate multifocal corrections. This approach offers an innovative solution to reduce the cost and size of visual simulators, making them more accessible.

The compact, wearable, and see-through nature of the device enhances the patient’s experience by allowing them to engage with the real world while wearing the simulated corrections.

It offers the flexibility to simulate various presbyopia-correcting combinations, including bifocal, trifocal, extended-depth-of-focus designs, monovision, and modified monovision.


Revolutionizing Decision-Making

The impact of SimVis on patient satisfaction and treatment decision-making has been remarkable. By experiencing different correction options firsthand, patients can make more informed choices, ultimately leading to greater satisfaction with the final outcomes. Clinical experiments conducted with presbyopes, simulated presbyopes, and cataract patients demonstrated the device’s effectiveness. Measurements of visual acuity, subjective preference assessments, and scoring of corrections in realistic visual settings showed clear differences in preferred corrections among patients. Trifocal designs were generally favored for intermediate distances, while monofocal corrections were preferred for distance vision. However, individual preferences varied, underscoring the importance of personalized solutions.


Future Prospects

2EyesVision aims to bring SimVis to the market by the end of this year. Additionally, the company is actively developing other technologies, including diagnostic devices and multifocal lens designs. Exciting prospects on the horizon include new patented paradigms for accommodating intraocular lenses (IOLs) and enhancing IOL engagement with the capsular bag. These advancements hold the potential to elevate presbyopic corrections to new levels of application, promising improved patient satisfaction and visual performance postoperatively.



SimVis Gekko emerges as a groundbreaking solution in the management of presbyopia, revolutionizing the way patients experience and choose visual corrections. By providing a tangible and immersive simulation of different correction options, SimVis empowers patients to make informed decisions and enhances their satisfaction with treatment outcomes. With ongoing research and development, SimVis and future advancements hold immense promise for transforming the field of presbyopic corrections and improving the lives of millions affected by this common vision condition.

Click to read more